Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | -7.69% | -7.69% | +9.09% |
03-29 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
03-19 | RAMM Pharma Corp. cancelled the transaction announced on September 5, 2023 | CI |
Sales 2022 | 3.9M 2.84M 228M | Sales 2023 | 5.07M 3.69M 296M | Capitalization | 5.97M 4.35M 349M |
---|---|---|---|---|---|
Net income 2022 | -21M -15.3M -1.23B | Net income 2023 | -7M -5.1M -409M | EV / Sales 2022 | 3.95 x |
Net cash position 2022 | 9.09M 6.62M 531M | Net cash position 2023 | 4.71M 3.43M 275M | EV / Sales 2023 | 0.25 x |
P/E ratio 2022 |
-1.17
x | P/E ratio 2023 |
-0.78
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.72% |
1 day | -7.69% | ||
1 week | -7.69% | ||
3 months | +20.00% | ||
6 months | +20.00% | ||
Current year | +9.09% |
Managers | Title | Age | Since |
---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/19 |
José Roldan
DFI | Director of Finance/CFO | - | 08/12/22 |
Edelma Ros
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Klein
BRD | Director/Board Member | 64 | 30/09/19 |
Daniel Augereau
BRD | Director/Board Member | 80 | 30/09/19 |
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/19 |
Date | Price | Change | Volume |
---|
Delayed Quote Canadian Securities Exchange, April 23, 2024 at 06:11 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+9.09% | 5.21M | |
+20.06% | 42.68B | |
-2.82% | 42.4B | |
+45.04% | 40.04B | |
-6.20% | 28.31B | |
+4.86% | 24.94B | |
-21.53% | 18.96B | |
+29.29% | 12.3B | |
-4.10% | 11.95B | |
-4.95% | 11.55B |
- Stock Market
- Equities
- RAMM Stock